Organomolecular Ferroelectric Nanocatalyst Augments Tumor Immunotherapy by Inducing Apoptosis and Ferroptosis
Advanced Materials · 2025
DOI: 10.1002/adma.202417422 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2025. Verfasst von Huning Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, China. Hauptthemen laut MEDLINE: Ferroptosis, Apoptosis, Immunotherapy, Nanoparticles. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Science Fund for Excellent Young Scholars, National Natural Science Fund for Young Scholars.
Abstract (Originalsprache)
Immunogenic programmed cell death effectively triggers acute inflammatory responses, thereby enhancing antitumor immunity. The advancement of biodegradable nonmetallic dual inducers represents a promising strategy. Herein, a biodegradable organomolecular ferroelectric nanoplatform (C 60 ‐TCNQ, CT) is designed to facilitate effective ferroelectric catalysis, thereby augmenting tumor immunotherapy through apoptosis and ferroptosis. CT‐mediated ultrasound‐triggered ferroelectric catalysis promotes ferroelectric polarization and significantly increases the production of reactive oxygen species, leading to substantial tumor cell apoptosis. Moreover, the polycyano group of CT nanoparticles selectively reacts with cysteine under mild conditions, resulting in redox imbalances and the accumulation of lipid peroxides, which contribute to the induction of ferroptosis in tumor cells. Additionally, the apoptosis and ferroptosis induced by CT stimulate immunogenic cell death progression, eliciting robust immune responses. In vivo evaluation using a bilateral tumor model demonstrates the capacity of CT to sensitize anti‐PD‐L1 therapy under ultrasound irradiation, achieving an impressive antitumor response rate of 96.2% against malignant melanoma and an 80% inhibition of tumor metastasis. RNA sequencing analysis revealed that treatment with CT resulted in a downregulation of gene signatures associated with the immune‐related Jak‐Stat signaling pathway. This study opens a novel avenue to developing organomolecular ferroelectric nanomedicines for effective tumor immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ultrasound National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, China.
- Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, China.
- Shanghai Key Laboratory of Functional Materials Chemistry, Key Laboratory for Advanced Materials, School of Chemistry and Molecular Engineering, East China University of Science and Technology, Shanghai, 200237, China.
ORCID-Profile: Huijing Xiang, Yu Chen, Hong Ding
Förderung
- National Natural Science Foundation of China
- National Science Fund for Excellent Young Scholars
- National Natural Science Fund for Young Scholars
- Shanghai Science and Technology Development Fund
- Shanghai Shuguang Program
- Shanghai Science and Technology Program
- Shanghai Rising-Star Program
- Key Science and Technology Research and Development Projects of Jiangxi Province
Zitieren
APA
Xu, H., Qiao, X., Liang, J., Qiu, L., Xue, L., Fang, Y., Xiang, H., Li, X., Chen, Y., & Ding, H. (2025). Organomolecular Ferroelectric Nanocatalyst Augments Tumor Immunotherapy by Inducing Apoptosis and Ferroptosis. Advanced Materials. https://doi.org/10.1002/adma.202417422
Vancouver
Xu H, Qiao X, Liang J, Qiu L, Xue L, Fang Y, et al. Organomolecular Ferroelectric Nanocatalyst Augments Tumor Immunotherapy by Inducing Apoptosis and Ferroptosis. Advanced Materials. 2025. doi:10.1002/adma.202417422
BibTeX
@article{Xu2025,
author = {Xu, Huning and Qiao, Xiaohui and Liang, Jing and Qiu, Luping and Xue, Liyun and Fang, Yan and Xiang, Huijing and Li, Xingguang and Chen, Yu and Ding, Hong},
title = {Organomolecular Ferroelectric Nanocatalyst Augments Tumor Immunotherapy by Inducing Apoptosis and Ferroptosis},
journal = {Advanced Materials},
year = {2025},
doi = {10.1002/adma.202417422}
}
EUVIMED